REVIEW
Add like
Add dislike
Add to saved papers

Takayasu's disease and temporal arteritis.

Takayasu's disease and temporal arteritis are similar entities that predominantly affect women. There are significant differences. Takayasu's disease is a rare disorder that affects the aorta and its main branches in young women, whereas temporal arteritis is a common disorder that affects small- to medium-sized arteries of elderly women. The pathology of Takayasu's disease extends to all three arterial layers, whereas in temporal arteritis the disease affects the media and adventitia less, with giant cells more prominent. The diagnosis of Takayasu's disease depends on clinical presentation and characteristics of angiography, whereas temporal arteritis is diagnosed by clinical findings and arterial biopsy. Steroids are only palliative in Takayasu's disease with a high incidence of recurrences, whereas steroids in temporal arteritis are curative with good long-term results. Finally, surgery plays an important role in the care of patients with Takayasu's disease, but is used infrequently in those patients diagnosed with temporal arteritis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app